Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-07-25

Clinical Trial Update: The Use of Oral Steroids in the Treatment of Cellulitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the use of oral steroids for cellulitis and erysipelas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral steroids (systemic corticosteroids)

Snippet

Sponsor: Milton S. Hershey Medical Center | Conditions: Cellulitis, Erysipelas | Phase 2 | Status: WITHDRAWN